
AccuLine
Developing CORA, a smart exam for early detection of coronary artery disease.
About
AccuLine Medical is a digital healthcare company focused on saving lives through early disease detection. They are developing CORA, a smart, accurate, and user-friendly exam designed for the early detection of coronary artery disease.
Key facts
At-a-glance profile data
- Website
- acculine-medical.com
- Founded
- 2022
- Employees
- 11
- Total funding
- $6M (Seed)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 14 Jul 2024 | Seed | $4M | eHealth Ventures, Maccabi Healthcare Services |
| 7 Jun 2022 | Pre-Seed | $1M | eHealth Ventures |
Tech stack
Detected on acculine-medical.com, last scanned 25 Jul 2026. Run your own scan
- Hosting
- Google Cloud
- Email provider
- Microsoft 365
Add first review
Frequently asked
How much funding has AccuLine raised?
AccuLine has raised a total of $6M in funding. The most recent round on record is Seed.
How many employees does AccuLine have?
AccuLine has approximately 11 people on record.
What is AccuLine's current status?
AccuLine's current operating status is: Inactive.
